Suchergebnisse: First Line

PD-1 inhibitors combined with paclitaxel and cisplatin in first-line treatment of esophageal squamous cell carcinoma (ESCC): a network meta-analysis

Zhao, Jia ; Zhang, Simeng ; Guo, Xiaoyu ; li, Ce ; Yang, Bowen ; Qu, Xiujuan ; Wang, Shuo

Publisher Correction: Interim survival analysis of the randomized phase III GEMSTONE-302 trial: sugemalimab or placebo plus chemotherapy as first-line treatment for metastatic NSCLC

Zhou, Caicun ; Wang, Ziping ; Sun, Meili ; Cao, Lejie ; Ma, Zhiyong ; Wu, Rong ; Yu, Yan ; Yao, Wenxiu ; Sun, Si ; Chen, Jianhua ; Zhuang, Wu ; Cui, Jiuwei ; Chen, Xueqin ; Lu, You ; Shen, Hong ; Hu, Chunhong ; Liu, Jiwei ; Liu, Yunpeng ; Wang, Mengzhao ; Li, Xingya ; Sun, Ping ; Shu, Yongqian ; Zhou, Jianying ; Li, Jingzhang ; Gu, Kangsheng ; Wang, Changli ; Zhao, Hui ; Zhang, Yiping ; Liu, Chunling ; Wang, Jingru ; Chen, Rumei ; Qin, Mengmeng ; Wang, Hao ; Yang, Jason

Author Correction: Real-world ANASTASE study of atezolizumab+nab-paclitaxel as first-line treatment of PD-L1-positive metastatic triple-negative breast cancer

Fabi, Alessandra ; Carbognin, Luisa ; Botticelli, Andrea ; Paris, Ida ; Fuso, Paola ; Savastano, Maria Cristina ; Verde, Nicla La ; Strina, Carla ; Pedersini, Rebecca ; Guarino, Stefania ; Curigliano, Giuseppe ; Criscitiello, Carmen ; Raffaele, Mimma ; Beano, Alessandra ; Franco, Antonio ; Valerio, Maria Rosaria ; Verderame, Francesco ; Fontana, Andrea ; Haspinger, Eva Regina ; Caldara, Alessia ; Leone, Alba Di ; Tortora, Giampaolo ; Giannarelli, Diana ; Scambia, Giovanni

Correction to: Over-the-Scope Clips Versus Standard Endoscopic Treatment for First Line Therapy of Non-variceal Upper Gastrointestinal Bleeding: Systematic Review and Meta-Analysis

Faggen, Alec E. ; Kamal, Faisal ; Lee‑Smith, Wade ; Khan, Muhammad Ali ; Sharma, Sachit ; Acharya, Ashu ; Ahmed, Zohaib ; Farooq, Umer ; Bayudan, Alexis ; McLean, Richard ; Avila, Patrick ; Dai, Sun‑Chuan ; Munroe, Craig A. ; Kouanda, Abdul

Correction: Feasibility of oral doxycycline as first-line therapy for conjunctival mucosa-associated lymphoid tissue lymphoma

Choi, Se Hyun ; Yang, Min Kyu ; Kim, Tae Min ; Choi, Hyuk Jin

Author Correction: Real-world ANASTASE study of atezolizumab+nab-paclitaxel as first-line treatment of PD-L1-positive metastatic triple-negative breast cancer

Fabi, Alessandra ; Carbognin, Luisa ; Botticelli, Andrea ; Paris, Ida ; Fuso, Paolo ; Savastano, Maria Cristina ; Verde, Nicla La ; Strina, Carla ; Pedersini, Rebecca ; Guarino, Stefania ; Curigliano, Giuseppe ; Criscitiello, Carmen ; Raffaele, Mimma ; Beano, Alessandra ; Franco, Antonio ; Valerio, Maria Rosaria ; Verderame, Francesco ; Fontana, Andrea ; Haspinger, Eva Regina ; Caldara, Alessia ; Leone, Alba Di ; Tortora, Giampaolo ; Giannarelli, Diana ; Scambia, Giovanni

Correction to: First-line nivolumab plus ipilimumab in metastatic non-small cell lung cancer: 5-year outcomes in Japanese patients from CheckMate 227 Part 1

Nishio, Makoto ; Ohe, Yuichiro ; Ikeda, Satoshi ; Yokoyama, Toshihide ; Hayashi, Hidetoshi ; Fukuhara, Tatsuro ; Sato, Yuki ; Tanaka, Hiroshi ; Hotta, Katsuyuki ; Sugawara, Shunichi ; Daga, Haruko ; Okamoto, Isamu ; Kasahara, Kazuo ; Naito, Tateaki ; Li, Li ; Gupta, Ravi G. ; Bushong, Judith ; Mizutani, Hideaki

Pola-R-CHP performed well in first-line Polarix trial-ineligible and IPI 0–1 DLBCL patients – Article type: research

Ren, Yuhong ; Cheng, Luya ; Zhuang, Jingli ; Wang, Zhimei ; Yuan, Ling ; Cheng, Zhixiang ; Ke, Yang ; Wang, Weiguang ; Li, Jing ; Liu, Peng

Correction to: Podcast to Discuss Therapy Management for Patients with Metastatic Renal Cell Carcinoma Receiving First-Line Axitinib Plus an Immune Checkpoint Inhibitor

Ornstein, Moshe C. ; Wood, Laura S.

Correction to: Real-world multicentre cohort of first-line pembrolizumab alone or in combination with platinum-based chemotherapy in non-small cell lung cancer PD-L1 ≥ 50%

Pons-Tostivint, E. ; Hulo, P. ; Guardiolle, V. ; Bodot, L. ; Rabeau, A. ; Porte, M. ; Hiret, S. ; Demontrond, P. ; Curcio, H. ; Boudoussier, A. ; Veillon, R. ; Mayenga, M. ; Dumenil, C. ; Chatellier, T. ; Gourraud, P. A. ; Mazieres, J. ; Bennouna, J.

First-line checkpoint inhibitor therapy in metastatic acral lentiginous melanoma compared to other types of cutaneous melanoma: a multicenter study from the prospective skin cancer registry ADOREG

Reinhard, Sören ; Utikal, Jochen ; Zaremba, Anne ; Lodde, Georg Christian ; von Wasielewski, Imke ; Klespe, Kai Christian ; Meier, Friedegund ; Haferkamp, Sebastian ; Kähler, Katharina C. ; Herbst, Rudolf ; Gebhardt, Christoffer ; Sindrilaru, Anca ; Dippel, Edgar ; Angela, Yenny ; Mohr, Peter ; Pfoehler, Claudia ; Forschner, Andrea Lydia ; Kaatz, Martin ; Schell, Beatrice ; Gesierich, Anja ; Loquai, Carmen ; Hassel, Jessica C. ; Ulrich, Jens ; Meiß, Frank ; Schley, Gaston ; Heinzerling, Lucie M. ; Sachse, 2025 Universität Augsburg

Presence of brain metastasis differentially impacts long-term survival after first-line therapy in melanoma depending on BRAF mutation status

Placke, Jan-Malte ; Rajcsanyi, Luisa Sophie ; Herbst, Rudolf ; Terheyden, Patrick ; Utikal, Jochen ; Pföhler, Claudia ; Kreuter, Alexander ; Mohr, Peter ; Gutzmer, Ralf ; Weichenthal, Michael ; Meier, Friedegund ; Berking, Carola ; Leiter-Stöppke, Ulrike ; Seier, Johanna ; Krefting, Frederik ; Tasdogan, Alpaslan ; Lodde, Georg C. ; Livingstone, Elisabeth ; Zimmer, Lisa ; Roesch, Alexander ; Griewank, Klaus ; Schadendorf, Dirk ; Ugurel, Selma 2025 Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)

Correction: Cost-effectiveness analysis of sintilimab plus pemetrexed and platinum versus chemotherapy alone as first-line treatment in metastatic non-squamous non–small cell lung cancer in China

Liu, Huiqin ; Wang, Ying ; He, Qi

Correction to: First-Line Treatment of Advanced Non-Small-Cell Lung Cancer with Immune-Checkpoint Inhibitors: New Combinations and Long-Term Data

Boussageon, Maxime ; Swalduz, Aurélie ; Chouaid, Christos ; Bylicki, Olivier

Author Correction: The real-world selection of first-line systemic therapy regimen for metastatic gastroenteropancreatic neuroendocrine neoplasm in Japan

Yamamoto, Shun ; Sakakibara, Naoki ; Hirano, Hidekazu ; Morizane, Chigusa ; Honma, Yoshitaka ; Hijioka, Susumu ; Okusaka, Takuji ; Higashi, Takahiro ; Kawai, Akira

Correction to: The Difference in Clinical Outcomes Between Osimertinib and Afatinib for First-Line Treatment in Patients with Advanced and Recurrent EGFR-Mutant Non-Small Cell Lung Cancer in Taiwan

Huang, Yen-Hsiang ; Hsu, Kuo-Hsuan ; Tseng, Jeng-Sen ; Yang, Tsung-Ying ; Chen, Kun-Chieh ; Su, Kang-Yi ; Yu, Sung-Liang ; Chen, Jeremy J. W. ; Chang, Gee-Chen

Correction to: Clinical usefulness of eribulin as first- or second-line chemotherapy for recurrent HER2-negative breast cancer: a randomized phase II study (JBCRG-19)

Aogi, Kenjiro ; Watanabe, Kenichi ; Kitada, Masahiro ; Sangai, Takafumi ; Ohtani, Shoichiro ; Aruga, Tomoyuki ; Kawaguchi, Hidetoshi ; Fujisawa, Tomomi ; Maeda, Shigeto ; Morimoto, Takashi ; Sato, Nobuaki ; Takao, Shintaro ; Morita, Satoshi ; Masuda, Norikazu ; Toi, Masakazu ; Ohno, Shinji

Correction to: Cost-Effectiveness Analysis of Olaparib in Combination with Bevacizumab Compared with Bevacizumab Monotherapy for the First-Line Maintenance Treatment of Homologous Recombination Deficiency-Positive Advanced Ovarian Cancer

Elsea, David ; Fan, Lin ; Mihai, Adela ; Moustaid, Fadoua El ; Simmons, Daniel ; Monberg, Matthew ; Muston, Dominic

Correction to: Primary Tumor Resection for Stage IV Non-small-cell Lung Cancer Without Progression After First-Line Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Treatment: A Retrospective Case–Control Study

Kuo, Shuenn-Wen ; Chen, Pei-Hsing ; Lu, Tzu-Pin ; Chen, Ke-Cheng ; Liao, Hsien-Chi ; Tsou, Kuan-Chuan ; Tsai, Tung-Ming ; Lin, Mong-Wei ; Hsu, Hsao-Hsun ; Chen, Jin-Shing

Erratum to: Docetaxel – A Review of its Use for the First-Line Treatment of Advanced Castration-Resistant Prostate Cancer

McKeage, Kate